AI Terminal
Indivior PLC
Board/Management Information • May 10, 2024
4923_rns_2024-05-10_7355667d-5218-48c0-8f0d-f02f2ffff60f.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8838N
Indivior PLC
10 May 2024
Indivior PLC - Board Committee Changes
Slough, UK and Richmond, VA, May 10, 2024 - Indivior PLC announces that Dr. David Wheadon, who will join the Board as an Independent Non-Executive Director on June 1, 2024, has been appointed as a member of the Nomination, Remuneration and Science Committees also with effect from June 1, 2024.
Furthermore, in order to comply with Nasdaq's listing rule that requires the Nomination Committee be comprised solely of Independent Directors, Jerome Lande has advised the Board that he will step down as a member of the Nomination Committee with effect from May 31, 2024. Mr. Lande is a Representative Director of Scopia Capital Management LP, who are a significant shareholder of the Group.
Following these changes, the membership of the Nomination, Remuneration and Science Committees will be as follows:
Nomination Committee
Graham Hetherington (Chair)
Peter Bains
Joanna Le Couilliard
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Juliet Thompson
Dr. David Wheadon
Remuneration Committee
Joanna Le Couilliard (Chair)
Peter Bains
Graham Hetherington
Barbara Ryan
Dr. David Wheadon
Science Committee
Peter Bains (Chair)
Dr. Keith Humphreys
Barbara Ryan
Mark Stejbach
Dr. David Wheadon
This announcement is made in accordance with Listing Rule 9.6.11.
Kathryn Hudson
Company Secretary
Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAKKLFBZELLBBQ